Cargando…
P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430006/ http://dx.doi.org/10.1097/01.HS9.0000973272.98235.10 |
| _version_ | 1785090850707996672 |
|---|---|
| author | Lo, Siu Hing Aggio, Daniel Gatta, Francesca Ong, Moh-Lim Wang, Yan |
| author_facet | Lo, Siu Hing Aggio, Daniel Gatta, Francesca Ong, Moh-Lim Wang, Yan |
| author_sort | Lo, Siu Hing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430006 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104300062023-08-17 P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS Lo, Siu Hing Aggio, Daniel Gatta, Francesca Ong, Moh-Lim Wang, Yan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430006/ http://dx.doi.org/10.1097/01.HS9.0000973272.98235.10 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lo, Siu Hing Aggio, Daniel Gatta, Francesca Ong, Moh-Lim Wang, Yan P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title | P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title_full | P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title_fullStr | P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title_full_unstemmed | P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title_short | P1599: REAL-WORLD CLINICAL PRACTICES IN TREATMENT DISCONTINUATION WITH COMPLEMENT C5 INHIBITORS FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME: A GLOBAL SURVEY OF HEALTHCARE PROFESSIONALS |
| title_sort | p1599: real-world clinical practices in treatment discontinuation with complement c5 inhibitors for atypical hemolytic uremic syndrome: a global survey of healthcare professionals |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430006/ http://dx.doi.org/10.1097/01.HS9.0000973272.98235.10 |
| work_keys_str_mv | AT losiuhing p1599realworldclinicalpracticesintreatmentdiscontinuationwithcomplementc5inhibitorsforatypicalhemolyticuremicsyndromeaglobalsurveyofhealthcareprofessionals AT aggiodaniel p1599realworldclinicalpracticesintreatmentdiscontinuationwithcomplementc5inhibitorsforatypicalhemolyticuremicsyndromeaglobalsurveyofhealthcareprofessionals AT gattafrancesca p1599realworldclinicalpracticesintreatmentdiscontinuationwithcomplementc5inhibitorsforatypicalhemolyticuremicsyndromeaglobalsurveyofhealthcareprofessionals AT ongmohlim p1599realworldclinicalpracticesintreatmentdiscontinuationwithcomplementc5inhibitorsforatypicalhemolyticuremicsyndromeaglobalsurveyofhealthcareprofessionals AT wangyan p1599realworldclinicalpracticesintreatmentdiscontinuationwithcomplementc5inhibitorsforatypicalhemolyticuremicsyndromeaglobalsurveyofhealthcareprofessionals |